FIELD: chemistry.
SUBSTANCE: invention relates to the use of 11-(4-tert-butylbenzyl)-2,3,4,5-tetrahydro[1,3]diazepino[1,2-a]benzimidazole hydrobromide of formula 1 as an agent having anxiolytic and anticonvulsant activity. 1.
EFFECT: use of a hydrobromide of formula 1 as an agent having simultaneously anxiolytic and anticonvulsant activity has been proposed.
1 cl, 5 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
11-(4-TRET-BUTYLBENZYL) - AND PHENACYLREPLACED 2,3,4,5-TETRAHYDRO [1,3] DIAZEPINO [1,2-a] BENZIMIDAZOLE WITH ANXIOLYTIC ACTIVITY | 2016 |
|
RU2629022C1 |
HYDROHALOGENIDE OF 1-(3,4-DIMETHOXYPHENYL)-2-(7,8-DIMETHYL-2,3,4,5-TETRAHYDRO-1,3]DIAZEPINO[1,2A]BENZIMIDAZOLE-11-YL)ETHANONE WITH ANALGESIC AND ANXIOLYTIC ACTIVITY | 2016 |
|
RU2636785C1 |
NEW N-ARYLSULPHAMIDE DERIVATIVE OF O-BENZOILAMINE-BENZOIC ACID WITH ANXIOLYTIC, ACTOPROTECTIVE AND ANTIDEPRESSANT ACTIVITY | 2016 |
|
RU2643356C2 |
METHOD OF PRODUCING 1(11)H-2,3,4,5-TETRAHYDRO[1,3]DIAZEPINO[1,2-a]BENZIMIDAZOLE | 2023 |
|
RU2814769C1 |
AGENT POSSESSING ANXIOLYTHIC ACTION, ON BASIS OF HYDROGENATED PYRIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND WAY OF ITS APPLICATION | 2007 |
|
RU2338533C1 |
HYDROHALIDES OF 11-PHENOXYETHYL AND 11-BENZYL-SUBSTITUTED 2,3,4,5-TETRAHYDRO[1,3]DIAZEPINO[1,2-a] BENZIMIDAZOLE, HAVING ANTIAGGREGANT ACTIVITY | 2015 |
|
RU2582618C1 |
ANTIDEPRESSANT, ANXIOLYTIC, NEUROPROTECTIVE AND IMMUNOSTIMULATING AGENT | 2010 |
|
RU2429834C1 |
ANXIOLYTIC AGENT | 2017 |
|
RU2655929C1 |
PHARMACEUTICAL COMPOSITION FOR THE ELIMINATION OF CONVULSIVE SYNDROME BASED ON NIKETHAMIDE AND MEDICINAL PRODUCTS OF THE BENZODIAZEPINE GROUP | 2022 |
|
RU2801050C1 |
ANTISPASMODIC MEDICATION | 2014 |
|
RU2568841C1 |
Authors
Dates
2018-07-25—Published
2017-07-25—Filed